ECOR
electroCore, Inc.·Healthcare
9.24
3.704%(+0.33)
Close PriceLast Updated: — ET
52W L: $4.1652W H: $9.68
ECOR NEWS
marketbeat.com
May 19
electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference
electroCore NASDAQ: ECOR Interim President and CFO Joshua Lev said the bioelectronic technology company is focused on expanding its non-invasive vagus nerve stimulation platform across federal health care, commercial insurance channels and consumer wellness markets.
globenewswire.com
May 13
electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia
ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in JAMA Network Open titled, “Transcutaneous Electrical Nerve Stimulation and Pain With Movement in People With Fibromyalgia: A Cluster Randomized Clinical Trial.
globenewswire.com
May 8
electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026
ROCKAWAY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the LD Micro Invitational XVI Conference being held at the Luxe Sunset Boulevard hotel in Los Angeles, CA. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one meetings throughout the day.
seekingalpha.com
May 7
electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript
electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript
zacks.com
May 6
electroCore, Inc. (ECOR) Reports Q1 Loss, Beats Revenue Estimates
electroCore, Inc. (ECOR) came out with a quarterly loss of $0.59 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.47 per share a year ago.
globenewswire.com
May 6
electroCore Announces First Quarter 2026 Financial Results
First quarter 2026 net sales of $9.6 million, an increase of 43% over $6.7 million in the first quarter 2025 Net loss of $5.3 million with Adjusted EBITDA net loss improving 24% from prior-year period to $2.3 million Company to host a conference call and webcast today, May 6, 2026, at 4:30 pm EDT ROCKAWAY, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced financial results for the first quarter ended March 31, 2026.
